Large granular lymphocyte leukemia: Natural history and response to treatment

Leukemia and Lymphoma

Volumn 51, Issue 5, 2010, Pages 839-845

  Fortune, Anne F ^a   Kelly, Kevin ^a   Sargent, Jeremy ^b   O'Brien, David ^a   Quinn, Fiona ^a   Chadwick, Nick ^a   Flynn, Catherine ^a   Conneally, Eibhlin ^a   Browne, Paul ^a   Crotty, Gerard M ^c   Thornton, Patrick ^b   Vandenberghe, Elisabeth ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c Tullamore General Hospital   (Ireland)

Author keywords

Alemtuzumab; LGL leukemia; Pentostatin; TCR

Indexed keywords

ALEMTUZUMAB; CHLORAMBUCIL; CYCLOSPORIN; LACTATE DEHYDROGENASE; METHOTREXATE; PENTOSTATIN; RHEUMATOID FACTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOPENIA; DRUG RESPONSE; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FATIGUE; FEMALE; FEVER; GENE REARRANGEMENT; HALLUCINATION; HUMAN; HYPERGAMMAGLOBULINEMIA; KIDNEY DYSFUNCTION; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOSIS; MALE; MOUTH ULCER; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT INFECTION; SPLENOMEGALY; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; METHOTREXATE; MIDDLE AGED; PENTOSTATIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77951772440     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428191003706947     Document Type: Article

References (51)

1. Brouet JC, Sasportes M, Flandrin G, Preud'Homme JL, Seligmann M. Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients. Lancet 1975;2:890-893.
2. McKenna RW, Parkin J, Kersey JH, Gajl-Peczalska KJ, Peterson L, Brunning RD. Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultra structural and membrane surface marker characteristics. Am J Med 1977;62:588-596.
3. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukaemia. Blood Rev 1999;13:230-240.
4. Lamy T, Loughran TP. Large granular lymphocyte leukaemia. Cancer Control 1998;5:25-33.
5. Loughran TP Jr. Clonal disease of large granular lymphocytes. Blood 1993;82:1-14.
6. Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin Hematol 2003;40:185-195.
7. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of tumours of hematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press; 2008. pp 272-273.
8. Epling-Burnette PK, Loughran TP Jr. Survival signals in leukaemic large granular lymphocytes. Semin Hematol 2003;40:213-220.
9. Wlodarski MW, O'Keeffe C, Howe EC, et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 2005;106:2769-2780.
10. Loughran TP Jr, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992;80:1116-1119.
11. Loughran TP Jr, Sherman MP, Ruscetti FW, et al. Prototypical HTLV-I/II infection is rare in LGL leukemia. Leuk Res 1994;18:423-429.
12. Loughran TP Jr, Hadlock KG, Perzova R. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998;101:318-324.
13. Sokol L, Agrawal D, Loughran TP Jr. Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia. Leuk Res 2005;29:381-387.
14. Thomas A, Perzova R, Abbott L, et al. LGL leukemia and HTLV. AIDS Res Hum Retroviruses 2010;26:33-40.
15. Lamy T, Liu JH, Landowski TH, et al. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3 (+) large granular lymphocyte leukemia. Blood 1998;92:4771-4777.
16. Epling-Burnette PK, Bai F, Wei S, et al. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 2004;23:9220-9229.
17. Schade AE, Powers JJ, Wlodarski MW, Maciejewski JP. Phosphatidylinositol- 3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 2006;107:4834-4840.
18. Au WY, Lam CC, Lie AK, Pang A, Kwong YL. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol 2003;120:626-630.
19. Mohty M, Faucher C, Vey N, et al. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis. Leukemia 2002;16:2129-2133.
20. Chang H, Kamel-Reid S, Hussain N, et al. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders. Am J Clin Pathol 2005;123:196-199.
21. Feher O, Barilla D, Locker J, et al. T-cell large granular lymphocytic leukemia following orthotopic liver transplantation. Am J Hematol 1995;49:216-220.
22. Gentile TC, Hadlock KG, Uner AH, et al. Large granular lymphocyte leukaemia occurring after renal transplantation. Br J Haematol 1998;101:507-512.
23. Osuji N, Matutes E, Tjonnfjord G, et al. T-cell large granular lymphocyte leukemia. A report on the treatment of 29 patients and a review of the literature. Cancer 2006;107:570-578.
24. Bible KC, Tefferi A. Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocyte leukaemia and chronic natural killer cell lymphocytosis. Br J Haematol 1996;93:406-408.
25. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukaemia with oral low dose methotrexate. Blood 1994;84:2164-2170.
26. Pawarode A, Wallace PK, Ford LA, Barcos M, Baer MR. Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia. Leuk Lymphoma 2010;51:338-341.
27. Fujishima N, Sawada K, Hirokawa M, et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 2008;93:1555-1559.
28. Thomssen C, Nissen C, Gratwohl A, Tichelli A, Stern A. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). Br J Haematol 1989;71:157-158.
29. Lang DF, Rosenfeld CS, Diamond HS, Shadduck RK, Zeigler ZR. Successful treatment of T-gamma lymphoproliferative disease with human-recombinant granulocyte colony stimulating factor. Am J Hematol 1992;40:66-68.
30. Mulder AB, de Wolf JT, Smit JW, van Oostveen JW, Vellenga E. Correction of neutropenia by GM-CSF in patients with a large granular lymphocyte proliferation. Ann Hematol 1992;65:91-95.
31. Genvresse I, Späth-Schwalbe E, Lukowsky A, Possinger K. Delayed response to granulocyte colony-stimulating factor (G-CSF) in a case of severe neutropenia associated with large granular lymphocyte (LGL) leukemia. Eur J Haematol 1998;60:133-134.
32. Mercieca J, Matutes E, Dearden C, MacLennan K, Catovsky D. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol 1994;12:2588-2593.
33. Osuji N, Del Giudice I, Matutes E, et al. CD52 expression in T-cell large granular lymphocyte leukaemia - implications for treatment with alemtuzumab. Leuk Lymphoma 2005;46:723-727.
34. Mohan SR, Clemente MJ, Afable M, et al. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+large granular lymphocyte leukemia. Haematologica 2009;94:1407-1414.
35. Dincol G, Diz-Kuçukkaya R, Bicakci E. T-cell large granular lymphocytic leukaemia: successful response to 2-deoxycoformycin. Neth J Med 2008;66:85-87.
36. Subbiah V, Viny AD, Rosenblatt S, Pohlman B, Lichtin A, Maciejewski JP. Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. Exp Hematol 2008;36:1078-1083.
37. Van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukaemia 2003;17:2257-2317.
38. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994;84:1620-1627.
39. Scott CS, Richards SJ, Sivakumaran M, Short M, et al. Transient and persistent expansions of large granular lymphocytes (LGL) and natural killer associated cells: the Yorkshire Leukaemia Group Study. Br J Haematol 1993;83:505-515.
40. Sretenovic A, Antic D, Jankovic S, et al. T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience. Med Oncol 2009 Mar. 21. [Epub ahead of print]
41. Gonzales-Chambers R, Przepiorka D, Winkelstein A, et al. Lymphocyte subsets associated with T cell receptor beta chain gene rearrangement in patients with rheumatoid arthritis and neutropaenia. Arthritis Rheum 1992;35:516-520.
42. Snowden N, Bhavani M, Swinson DR, et al. Large granular lymphocytes, neutropaenia and polyarthropathy. An under diagnosed syndrome. Q J Med 1991;78:65-76.
43. Boveri E, Riboni R, Antico P, Malacrida A, Pastorini A. CD3+ T large granular lymphocyte leukaemia in a HIV+, HCV+, HBV+ patient. Virchows Arch 2009;454:349-351.
44. Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropaenia. Hematology Am Soc Hematol Educ Program 2004; 63-79.
45. Huh YO, Medeiros LJ, Ravandi F, Konoplev S, Jorgensen JL, Miranda RN. T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases. Am J Clin Pathol 2009;131:347-356.
46. Saunthararajah Y, Molldrem J, Rivera M, et al. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathological features. Br J Haematol 2001;112:195-200.
47. Aribi A, Huh Y, Keating M, et al. T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years. Leuk Res 2007;31:939-945.
48. Dearden C. The role of alemtuzumab in the management of T-cell malignancies. Semin Oncol 2006;33(Suppl 5):S44-S52.
49. Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH. Efficacy of treatment for refractory T-cell large granular lymphocytic leukemia. Blood 2004;103:1969-1971.
50. Ru X, Liebman, HA. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol 2003;123:278-281.
51. Ravandi F, Aribi A, O'Brien S, et al. Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms. J Clin Oncol 2009;27:5425-5430.